Left main drug-eluting stents: natural progression or a bridge too far?
Stone
Gregg W
GW
Moses
Jeffrey W
JW
Leon
Martin B
MB
D015906:Angioplasty, Balloon, Coronary / Q000009:adverse effects* / Q000295:instrumentation; D000972:Antineoplastic Agents, Phytogenic / Q000008:administration & dosage; D019917:Blood Vessel Prosthesis Implantation / Q000009:adverse effects*; D001026:Coronary Artery Bypass; D023921:Coronary Stenosis / Q000601:surgery / Q000628:therapy*; D016503:Drug Delivery Systems; D006801:Humans; D017239:Paclitaxel / Q000008:administration & dosage; D016032:Randomized Controlled Trials as Topic; D015607:Stents; D016896:Treatment Outcome
D000972:Antineoplastic Agents, Phytogenic; D017239:Paclitaxel